Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2021

EA21 Newsletter: Session COVP1: Different perspectives looking back at Covid pandemic

Friday December 17, 17:45 – 18:45 – Channel 8

This three-part session reflecting on the COVID-19 pandemic to date will be opened by Dr Kariem El-Boghdadly, Consultant Anaesthetist at Guy’s & St Thomas’ NHS Foundation Trust, London, UK, who will discuss the timing of surgery after SARS-CoV-2 infection.

He will explain how surgery with active SARS-CoV-2 infection is associated with increased risks of complications and death. With an increasing number of patients having surgery after a recent or previous SARS-CoV-2 infection, there was a need for evidence to guide the safest timing of surgery in this growing cohort of patients. An international across 116 countries study of more than 140,000 patients was conducted, finding that the risks of death and complications were increased if surgery was performed within 7 weeks of a SARS-CoV-2 infection.

Patients with ongoing symptoms had a greater risk than those who have had symptom resolution. These risks remained high regardless of how unwell the patient was, and the nature and urgency of the operation they were having. These data fed into national guidelines in the UK by the Association of Anaesthetists, the Centre for Peri-operative Care, the Federation of Surgical Specialty Associations, the Royal College of Anaesthetists and the Royal College of Surgeons of England, who recommended that planned surgery should not be scheduled within 7 weeks of a diagnosis of SARS-CoV-2 unless the risks of delaying surgery are greater than the risks associated with COVID-19. Dr El-Boghdadly concludes: “These recommendations should increase the safety of surgery in patients who have had SARS-CoV-2 infection.”

The second talk in this session – ‘Lessons learned from Covid: the surgeons’ perspective’ – will be presented by Prof Dr Nicole Bouvy, a surgeon at Maastricht University Medical Center, Netherlands.

She says: “The COVID-19 pandemic and the lack of space in the operating rooms made us realise which surgical procedures are really important and which patients cannot be placed on a long waiting list. Patients on the waiting list for elective surgical procedures like hernia surgery realised that living with a for example non-symptomatic inguinal hernia at the age of 70 is not a big thing. By discussing OR indications in a multi-disciplinary team we learned a lot about real sensible care.”

Central OR planning makes the planning more effective so that the OR is fully occupied. Most of the time, procedures planned by plastic and reconstructive or orthopaedic surgeons had to be placed back on the waiting list. Prof Bouvy says: “Of course, we must find out if the quality of life of these patients is impaired.”

She adds: “Furthermore, this time of reflection helped us to make our operating room more sustainable. As hospitals are responsible for 25% of the total greenhouse effect in western countries, we started with a reduction of inhalation gases, a reduction of the air refreshment cycle and a reduction of our disposable instruments. Also, because raw materials were hard to get other materials were hard to get. This ‘green spirit’ in the hospital helped to better team building and makes the environment and people living in the neighbourhood of the hospital healthier.”

The final talk “Pain management beyond the pandemic. Latin American experience” will be given by Dr Carolina Haylock Loor (San Pedro Sula Hospital, Honduras).

She explained how, during the COVID-19 pandemic, the human family has experienced an extremely challenging situation, with massive uncertainty, impacting all dimensions: physical, emotional, spiritual, political, economic, social, technological, influencing the quality of life globally, bringing more suffering and pain.

“Latin American is no exception,” says Dr Haylock Loor. “With more than 600 million inhabitants, Latin American is considered the world’s most unequal region, and the pandemic has increased this inequality (GINI coefficient raised from 0.48 to 0.51). This discrepancy also occurs in pain and reaffirms the WHO publication in 2009 that ‘80% of the world population with moderate to severe pain lack of adequate access to pain treatment’, and with stressors of the pandemic, like loneliness, distancing, it persisted and worsened.”

The increasing global burden of pain, more notorious in LMICs, by trauma, post-operative, childbirth, arthritis, back pain, diabetes, cancer, HIV-AIDS, sickle cell disease, and now post-COVID-19 syndrome, results in more inequity and compelling a need for bridging the gap in this regional health issue. Although there is a lack of epidemiological data in Latin America, there are studies that estimate a prevalence of chronic pain in a range of 18 to 42% of the population. Another disparity is in medicines for treating pain. HICs use 90% of the morphine distributed worldwide and experience the opioid addiction crisis, while in contrast, LMICs use only 10% of the world’s opioids and suffer opiophobia, in Latin American due to unfounded fear of medical professionals to provoke addiction with their prescriptions, aggravated by limited opioid availability, lack of education in pain, healthcare policies with strict regulatory provisions and finally, untreated conditions that enlarge the burden of pain.

She concludes: “In summary, pain does not wait for the pandemic to end; in Latin America, we started its management with telemedicine, in-person assessments, interventional procedures, pharmacological and non-pharmacological approaches. We must continue managing and educating our pain patients and trainees without tiring to struggle in the region to overcome the barriers mentioned.”


Read More of our special newsletter covering our virtual congress.